Literature DB >> 17396029

Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats.

Fan Yi1, Elisabete A dos Santos, Min Xia, Qi-Zheng Chen, Pin-Lan Li, Ningjun Li.   

Abstract

BACKGROUND/AIMS: We previously reported that increase in plasma homocysteine (Hcys) levels by a 6-week methionine treatment produced remarkable glomerular injury. However, the mechanism by which hyperhomocysteinemia (hHcys) produces glomerular injury remains unknown. The present study was to observe when glomerular injury happens during hHcys and to explore the possible role of podocyte injury in the progression of glomerulosclerosis associated with hHcys.
METHODS: Uninephrectomized Sprague-Dawley rats treated with methionine were used to examine the time course of glomerular injury induced by hHcys.
RESULTS: Creatinine clearance was not different until rats were treated with methionine for 6 weeks, although plasma Hcys levels significantly increased at the 1st week of methionine treatment. However, urinary albumin excretion increased at the 2nd week of methionine treatment. Morphological examinations showed that mesangial expansion occurred at the 2nd week and podocyte effacement was also observed as processed glomerular damage during hHcys. Immunofluorescence analyses demonstrated that podocin and nephrin expressions were reduced, while alpha-actinin-4 increased during hHcys.
CONCLUSIONS: Increased plasma Hcys level is an important pathogenic factor resulting in glomerular injury even in the very early time of hHcys. These pathogenic effects of Hcys are associated with podocyte injury and changed expression and distribution of podocyte-associated proteins. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396029     DOI: 10.1159/000101471

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  29 in total

1.  Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.

Authors:  Chun Zhang; Jun-Jun Hu; Min Xia; Krishna M Boini; Christopher A Brimson; Laura A Laperle; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

2.  Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease.

Authors:  Charumathi Sabanayagam; Anoop Shankar
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

Review 3.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

4.  Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.

Authors:  Chun Zhang; Min Xia; Krishna M Boini; Cai-Xia Li; Justine M Abais; Xiao-Xue Li; Laura A Laperle; Pin-Lan Li
Journal:  Pflugers Arch       Date:  2011-06-07       Impact factor: 3.657

5.  Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.

Authors:  Eun Young Kim; Marc Anderson; Stuart E Dryer
Journal:  Mol Pharmacol       Date:  2012-07-24       Impact factor: 4.436

Review 6.  Homocysteine in Renal Injury.

Authors:  Yanjun Long; Jing Nie
Journal:  Kidney Dis (Basel)       Date:  2016-04-27

Review 7.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

8.  Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes.

Authors:  Eun-Hee Cho; Eun Hee Kim; Won Gu Kim; Eun Hui Jeong; Eun Hee Koh; Woo-Je Lee; Min-Seon Kim; Joong-Yeol Park; Ki-Up Lee
Journal:  Korean Diabetes J       Date:  2010-06-30

9.  Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.

Authors:  Guangbi Li; Min Xia; Justine M Abais; Krishna Boini; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2016-05-11       Impact factor: 4.030

10.  Up regulation of the GRP-78 and GADD-153 and down regulation of Bcl-2 proteins in primary glomerular diseases: a possible involvement of the ER stress pathway in glomerulonephritis.

Authors:  Suchita Markan; Harbir Singh Kohli; Kusum Joshi; Ranjana Walker Minz; Kamal Sud; Monika Ahuja; Shashi Anand; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.